A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life.

Source:http://linkedlifedata.com/resource/pubmed/id/19042837

Download in:

View as

General Info

PMID
19042837